Replimune stock tumbles 20% after FDA raises efficacy concerns

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRNA
9. MRK
10. COTY

Go back to Replimune stock tumbles 20% after FDA raises efficacy concerns
Rider Explorations, Inc. (NASDAQ: REPL) Delayed: 14.05 -0.76 (5.13%)
Previous Close $14.81    52 Week High $1.45 
Open $14.55    52 Week Low $0.50 
Day High $14.77    P/E N/A 
Day Low $13.92    EPS $0.00 
Volume 4,294,738